Beltsville’s NextCure closes IPO – Washington Business Journal

By adminMay 20, 2019May 22nd, 2025No Comments

The net proceeds from the IPO, along with NextCure’s cash on hand, will largely be used to drive its lead product, NC318, through clinical trials and testing.

Tweet Share

About BioHealth Innovation

BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.

Learn More »

Contact

1 Church Street, Suite 801
Rockville, MD 20850
Email

Connect

Close Menu

SUBSCRIBE
CURRENT NEWSLETTER
ABOUT
PROGRAMS
BIOHEALTH NEWS
EVENTS
- EVENTS
- BIOHEALTH CAPITAL REGION FORUM REGISTRATION
CAREERS
- JOBS POSTINGS
- REGIONAL EMPLOYERS
BIOTALK

BIOHEALTH
BHCR INCENTIVES
CONTACT
SEARCH

Search

When autocomplete results are available use up and down arrows to review and enter to go to the desired page. Touch device users, explore by touch or with swipe gestures.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.